DimiCare Biotech 
goes FAR BEYOND  

Fighting Antimicrobial Resistance:
from the 
Biological EmergencY to Opportunistic and Neglected Diseases

What is DimiCare?

Dimicare Biotech is a spin-off from University Côte d'Azur (UniCA) focused on the development of a new generation of drugs against difficult-to-treat infections. Despite we are interested on different targets, our main project (DCB001) focuses on the development of a new precision treatment against MDR (multidrug-resistant) S. aureus strains (including the WHO priority MRSA; methicillin-resistance S. aureus).

Pipeline

DimiCare is building a great team involving academic researchers, infectiology and microbiology medical doctors, and strategic development experts, assuring a solid growth not only in the scientific but also in the business field.

Who is on board?

Operational team

Juan A. Garcia-Sanchez, PhD

 

Expert field: host-pathogen interaction - Antimicrobial Resistance (AMR)

 

Role in the futur start-up: CEO/CSO

 

Current role: Head of DimiCare Biotech at VIRINFLAM Team from C3M - INSERM U1065 - UniCA

Pauline Meola, MSc

 

Expert field: host-pathogen interaction - in vitro and in vivo infection models

 

Role in the futur start-up: CTO microbiology

 

Current role: Engineer in DimiCare Biotech project at VIRINFLAM Team from C3M - INSERM U1065 - UniCA

Research Board

Laurent Boyer, PhD

 

Expert field: host-pathogen interaction - Microbial virulence and host response

 

Role in the futur start-up: Co-founder "concours scientifique" - Microbiology - Inflammation expert 

 

Current role: Team leader (DRCN, HDR) at VIRINFLAM Team from C3M - INSERM U1065 - UniCA

Cyril Ronco, PhD

 

Expert field: medicinal chemistry - bioactive molecules against Human diseases

 

Role in the futur start-up: Co-founder "concours scientifique" - Medicinal Chemistry expert 

 

Current role: Team leader (MCUHC, HDR) at ICN - CNRS UMR7272 - UniCA

Grégory Michel, PhD

 

Expert field: host-parasite interaction - in vitro and in vivo infection models

 

Role in the futur start-up: Associate and "concours scientifique" - Host-parasite interaction expert 

 

Current role: Research Engineer (IR) at VIRINFLAM Team from C3M - INSERM U1065 - UniCA

Patrick Munro, PhD

 

Expert field: host-bacteria interaction - in vitro and in vivo infection models

 

Role in the futur start-up: Associate and "concours scientifique" - Host-bacteria interaction expert 

 

Current role: Researcher (CRHC) at VIRINFLAM Team from C3M - INSERM U1065 - UniCA

Clinical Board

Christelle Pomares-Estran, MD, PhD

 

Expert field: host-parasite interaction - Clinical parasitology and mycology

 

Role in the futur start-up: Co-founder "concours scientifique" - Parasitology and Mycology expert

 

Current role: Head of Department of Parasitology and Mycology (PU-PH, HDR) at CHU of Nice - UniCA

Raymond Ruimy, MD, PhD

 

Expert field: host-bacteria interaction - Clinical bacteriology

 

Role in the futur start-up: Clinical advisor - Bacteriology

 

Current role: Head of Department of Bacteriology (PU-PH, HDR) at CHU of Nice - UniCA

Business board

Johan Courjon , MD, PhD

 

Expert field: host-pathogen interaction - Clinical infectiology

 

Role in the futur start-up: Clinical advisor - Infectiology

 

Current role: Reference Doctor for infectious diseases associated to locomotor system at CHU of Nice - UniCA

O. D., PhD

 

Expert field: Financial strategy - Biotech/Pharmaceutical companies

 

Role in the futur start-up: Co-founder - Business development expert

 

Current role: Business developper

News!

Biorézo(TM) - Eurobiomed

We have been the pleasure to share on February the 15th the DimiCare's achievements, goals and challenges for this year. This event allowed us to interact with the local ecosystem, create new connections and consolide ancient ones.

February
2024

Prix Best Entrepreneurial Project - 06 Department

DimiCare has been awarded with the "Best Entrepreneurial Project" Award by the Entrepreneurial Union of the Department of "Alpes-Maritimes" - UPE06. 

December
2023

Staphosium (SFM)

On November 16th-17th people from all laboratories on France have concentred in Lyon to present their work about our Gold bacteria : Staphylococcus aureus. Of course, our project has been there to interact with other scientist and discuss about our main program DCB001. 

It has been a very interesting symposium in this amazing city.

November
2023

Magazine Inserm - Interview

DimiCare Biotech was the subject of the section of Inserm Magazine "Entrepreneurship". It is a real honor to see how our project is beginning to be recognized at a national level.

November
2023

Tribune Côte d'Azur - Interview

DimiCare Biotech was the subject of Tribune Côte d'Azur. Thank you for present our work to Côte d'Azur's citoyens !

October
2023

Pharmaceutiques - Interview

Our CEO talks about our experience with the SATT-SE, Incubateur and other innovation players in the Côte d'Azur ecosystem.

October
2023

My Innovation Is - SATT-SE

On October 12th, SATT Sud-Est organized “My Innovation Is” (MI2) an amazing event where many Deeptech projects were presented. MI2 was hosted at the Théâtre du Château de Valrose, and DimiCare Biotech was presented by our CEO in front of an excellent audience: members of the region's innovation ecosystem, colleagues and potential investors...

October
2023

2nd Annual Nucleate Summit in Sunny San Diego

Our Project leader has been invited to attend the 2nd Annual Nucleate Summit (23rd-25th August) in San Diego (USA), one of the biggest fast-growing international associations boosting biotech entrepreneurship in students and young researchers.

During this meeting, DimiCare has been introduced to many other projects in the healthtech environment and allowed to contact future partners and investors.

Thank you Nucleate to bringing us this opportunity and let's see what the future holds for this wonderful organization which has just started in France (particularly in Nice!). 

September
2023

DimiCare Biotech is supported by the South Region and SATT-SE through the Call of Projects
"Jeunes Docteurs Innovants" 

Last July, our project was announced as awarded of the Call for Projects "Young Innovative Doctors" from "Région Sud Provence-Alpes-Côte d'Azur". This Call for Projects is co-financed with the "SATT-Sud Est" which will participate on the "pre-maturation" of our project. This founding confirm a new year of work and advances in this amazing  Deeptech project.

Our project is now starting in an acceleration phase where the proof-of-concept of our technology is getting closer and closer, as well as the creation of our start-up.

August
2023

"i-PhD" National Innovation Award
"BpiFrance" 

The i-PhD, i-Lab and i-Nov Awards/Contest from the National Investment Public Bank "BpiFrance" hold the 4th Edition of National Innovation Prices in July 2023. These prices look for promote early-stage Deeptech startup projects (i-PhD) as well as young (i-Lab) and more advanced innovative companies (i-Nov).

During the Awards Ceremony which took place in Paris on July 4th, our entrepreneurial project was Awarded with the i-PhD Award. It includes a year of "business development training" for our future CEO, which will help us to mature our project and launch the startup in the following months. 

July
2023

Young entrepreneur Award
"Fondation UCA" - 06.2023

The Academic Excellence Award or Prix d'Excellence Académique is an initiative from Fondation UCA which has as its main objective to promote innovation and early-stage startup/spin-off projects coming from the University Côte d'Azur.

Our project has been awarded in the 2023 Edition and our future CEO Juan Garcia-Sanchez had the opportunity to pitch in front of many University Representatives and other entrepreneurs.

Thank "Fondation Université Côte d'Azur" for this Award which values our work and ICE - Innovation Center for Entrepreneurship which proposed our project.

June
2023

Welcome to the team Pauline!

Once obtaining YEP funding from SignaLife - Labex, the project decided to hire MSc. Pauline Meola, our future CTO in DimiCare.

Over the past few years, Pauline Meola has developed her skills in microbiology in the bacteriology department of the University Hospital of Nice (Determination of the virulence of clinical strains of multi-resistant Staphylococcus aureus) as well as in animal experimentation within the Mediterranean Center for Molecular Medicine. (C3M - U1065) in Nice (Development of new therapies against B-lymphoma). 

This mixed experience in microbiology and animal models made Pauline the perfect candidate to join DimiCare Biotech, we hope, for a long time.

Mai
2023

Young Entrepreneur Program "SignaLife - Labex" - 12.2022

The SignaLife - Labex Innovation Program has launched a YEP Call for Projects from 2020 with the following objectives: To support innovation within the scientific community of the SIGNALIFE Labex for projects developping new technological and scientific assets linked to research on cell signaling in biology, carried out by or in collaboration with SIGNALIFE Labex teams (IDEX partners), and whose planned development includes the creation of a startup.

DimiCare Biotech has been selected and awarded with this YEP founding which will allow us to work in the end of the early-discovery stage and to develop our proof-of-concept in the following months.

December 2022

Contact us!

Are you interested on our project?

 

Here are the different ways to contact us!

Supported by

Legal Notice © Copyright. All rights reserved. 

Nous avons besoin de votre consentement pour charger les traductions

Nous utilisons un service tiers pour traduire le contenu du site web qui peut collecter des données sur votre activité. Veuillez consulter les détails dans la politique de confidentialité et accepter le service pour voir les traductions.